Literature DB >> 25749709

Staphylococcus epidermidis serine--aspartate repeat protein G (SdrG) binds to osteoblast integrin alpha V beta 3.

T Claro1, N Kavanagh2, T J Foster3, F J O'Brien4, S W Kerrigan5.   

Abstract

Staphylococcus epidermidis is the leading etiologic agent of orthopaedic implant infection. Contamination of the implanted device during insertion allows bacteria gain entry into the sterile bone environment leading to condition known as osteomyelitis. Osteomyelitis is characterised by weakened bones associated with progressive bone loss. The mechanism through which S. epidermidis interacts with bone cells to cause osteomyelitis is poorly understood. We demonstrate here that S. epidermidis can bind to osteoblasts in the absence of matrix proteins. S. epidermidis strains lacking the cell wall protein SdrG had a significantly reduced ability to bind to osteoblasts. Consistent with this, expression of SdrG in Lactococcus lactis resulted in significantly increased binding to the osteoblasts. Protein analysis identified that SdrG contains a potential integrin recognition motif. αVβ3 is a major integrin expressed on osteoblasts and typically recognises RGD motifs in its ligands. Our results demonstrate that S. epidermidis binds to recombinant purified αVβ3, and that a mutant lacking SdrG failed to bind. Blocking αVβ3 on osteoblasts significantly reduced binding to S. epidermidis. These studies are the first to identify a mechanism through which S. epidermidis binds to osteoblasts and potentially offers a mechanism through which implant infection caused by S. epidermidis leads to osteomyelitis.
Copyright © 2015. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Bone infection; Osteoblast; Osteomyelitis; SdrG; Staphylococcus epidermidis; αVβ3

Mesh:

Substances:

Year:  2015        PMID: 25749709     DOI: 10.1016/j.micinf.2015.02.003

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  7 in total

Review 1.  Overview of Staphylococcus epidermidis cell wall-anchored proteins: potential targets to inhibit biofilm formation.

Authors:  Silvestre Ortega-Peña; Sergio Martínez-García; Sandra Rodríguez-Martínez; Mario E Cancino-Diaz; Juan C Cancino-Diaz
Journal:  Mol Biol Rep       Date:  2019-10-22       Impact factor: 2.316

Review 2.  Staphylococcal Osteomyelitis: Disease Progression, Treatment Challenges, and Future Directions.

Authors:  Nicola Kavanagh; Emily J Ryan; Amro Widaa; Gillian Sexton; Jerome Fennell; Sadhbh O'Rourke; Kevin C Cahill; Cathal J Kearney; Fergal J O'Brien; Steven W Kerrigan
Journal:  Clin Microbiol Rev       Date:  2018-02-14       Impact factor: 26.132

3.  The expression of glycosyltransferases sdgA and sdgB in Staphylococcus epidermidis depends on the conditions of biofilm formation.

Authors:  Itzia S Gómez-Alonso; Ilse D Estrada-Alemán; Sergio Martínez-García; Humberto Peralta; Erika T Quintana; Claudia Guerrero-Barajas; Cipriano Chávez-Cabrera; Sandra Rodríguez-Martínez; Mario E Cancino-Diaz; Juan C Cancino-Diaz
Journal:  Arch Microbiol       Date:  2022-04-21       Impact factor: 2.552

Review 4.  Staphylococcal Vaccine Antigens related to biofilm formation.

Authors:  Bahman Mirzaei; Ryhaneh Babaei; Sina Valinejad
Journal:  Hum Vaccin Immunother       Date:  2020-06-04       Impact factor: 3.452

Review 5.  Pathogenic Mechanisms and Host Interactions in Staphylococcus epidermidis Device-Related Infection.

Authors:  Marina Sabaté Brescó; Llinos G Harris; Keith Thompson; Barbara Stanic; Mario Morgenstern; Liam O'Mahony; R Geoff Richards; T Fintan Moriarty
Journal:  Front Microbiol       Date:  2017-08-02       Impact factor: 5.640

Review 6.  The Crossroads between Infection and Bone Loss.

Authors:  Tiago Carvalho Oliveira; Maria Salomé Gomes; Ana Cordeiro Gomes
Journal:  Microorganisms       Date:  2020-11-10

Review 7.  Virulence Factors in Coagulase-Negative Staphylococci.

Authors:  Angela França; Vânia Gaio; Nathalie Lopes; Luís D R Melo
Journal:  Pathogens       Date:  2021-02-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.